Evidence map›Paper›PMID 39199597›Full record

ArticleCancers2024

Pre-Op Hydronephrosis Predicts Outcomes in Patients Receiving Robot-Assisted Radical Cystectomy.

Chris Ho-Ming Wong, Ivan Ching-Ho Ko, David Ka-Wai Leung, Seok Ho Kang, Kousuke Kitamura, Shigeo Horie, Satoru Muto, Chikara Ohyama, Shingo Hatakeyama, Manish Patel and 9 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Chris Ho-Ming WongS.H. Ho Urology Centre, Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
Ivan Ching-Ho KoS.H. Ho Urology Centre, Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
David Ka-Wai LeungS.H. Ho Urology Centre, Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.ORCID 0000-0002-2078-7934
Seok Ho KangDepartment of Urology, Korea University Anam Hospital, Seoul 02841, Republic of Korea.
Kousuke KitamuraDepartment of Urology, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan.
Shigeo HorieDepartment of Urology, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan.
Satoru MutoDepartment of Urology, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan.ORCID 0000-0002-5400-5195
Chikara OhyamaDepartment of Urology, Hirosaki University, Hirosaki 036-8561, Japan.
Shingo HatakeyamaDepartment of Urology, Hirosaki University, Hirosaki 036-8561, Japan.ORCID 0000-0002-0026-4079
Manish PatelDepartment of Urology, The University of Sydney, Camperdown, NSW 2006, Australia.
Cheung-Kuang YangDepartment of Urology, Taichung Veterans General Hospital, Taichung 40705, Taiwan, China.
Kittinut KijvikaiDepartment of Urology, Ramathibodi Hospital, Mahidol University, Nakhon Pathom 10400, Thailand.
Ji Youl LeeDepartment of Urology, Catholic University of Korea, Seoul 07345, Republic of Korea.ORCID 0000-0001-6775-1157
Hai-Ge ChenDepartment of Urology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200030, China.
Rui-Yun ZhangDepartment of Urology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200030, China.
Tian-Xin LinDepartment of Urology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China.
Lui Shiong LeeDepartment of Urology, Sengkang General Hospital, Singapore 544886, Singapore.
Jeremy Yuen-Chun TeohS.H. Ho Urology Centre, Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.ORCID 0000-0002-9361-2342
Eddie ChanS.H. Ho Urology Centre, Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionRobot-assisted radical cystectomy (RARC) has gained momentum in the management of muscle invasive bladder cancer (MIBC). Predictors of RARC outcomes are not thoroughly studied. We aim to investigate the implications of preoperative hydronephrosis on oncological outcomes. PATIENTS AND

methodsThis study analysed data from the Asian RARC consortium, a multicentre registry involving nine Asian centres. Cases were divided into two groups according to the presence or absence of pre-operative hydronephrosis. Background characteristics, operative details, perioperative outcomes, and oncological results were reviewed. Outcomes were (1) survival outcomes, including 10-year disease-free survival (DFS) and overall survival (OS), and (2) perioperative and pathological results. Multivariate regression analyses were performed on survival outcomes.

resultsFrom 2007 to 2020, 536 non-metastatic MIBC patients receiving RARC were analysed. 429 had no hydronephrosis (80.0%), and 107 (20.0%) had hydronephrosis. Hydronephrosis was found to be predictive of inferior DFS (HR = 1.701,

conclusionsThe presence of preoperative hydronephrosis among MIBC patients carries additional prognostic implications on top of tumour staging. Its importance in case selection needs to be highlighted.

Indexed as

bladder cancerhydronephrosismuscle-invasive bladder cancerpre-operative assessmentrobot-assisted radical cystectomy

Identifiers

PMID39199597
PMCPMC11353176

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.